CTOs on the Move

Project Advisors Intl

www.paiworld.com

 
Project Advisors Intl is a Fairfax Station, VA-based company in the Business Services sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.paiworld.com
  • 6519 Ryanlynn Dr
    Fairfax Station, VA USA 22039
  • Phone: 703.250.3447

Executives

Name Title Contact Details

Similar Companies

Persogenics

Persogenics is a Provo, UT-based company in the Business Services sector.

Security Properties

Security Properties Residential (formerly Madrona Ridge Residential) is the affiliated full-service property management firm of Security Properties, created to increase the value of its real estate holdings by more closely managing its assets. Security Properties Residential is committed to delivering exceptional property management services to its apartment communities and residents throughout the Western United States. Property, construction, and compliance management expertise create positive living environments for residents and build value for clients.

Identiti

We get signage. And we get it done right. Planning, Managing, Fabricating, Installing, and Maintaining - Nationwide. #ThisIsAPromise

Megaphone TV

Megaphone TV is a Participation Entertainment Studio that develops multiplayer interactive TV applications, custom designed TV shows, and commercials.

CN Bio

We generate human-specific efficacy and safety data with pioneering PhysioMimix™ single- and multi-organ-on-a-chip solutions. Our advantage comes from having had almost unparalleled resources to invest in the development of leading edge organ-chips thanks to more than $32 Million in grants and contracts from DARPA, NIH, EU FP7, Innovate UK and NC3Rs. These programs have led to the development of a 7-organ human body-on-a-chip model (DARPA), a liver-on-a-chip model of cancer metastasis (NIH), a full viral lifecycle organ-chip model of hepatitis B and a liver-on-a-chip model of non-alcoholic fatty liver disease and steatohepatitis (NAFLD/NASH). CN Bio is at the forefront of translating these promising technologies from leading academic laboratories into the hands of pharmaceutical researchers for the development of new medicines to treat and cure disease and to the wider academic community seeking to understand biology and disease pathology using technologies which more closely represent the human response.